XPAR: SAN
Last close prices updated as of
Jun 09, 2023, 5:38 PM CET
| EUR
- Last Close 95.40
- Sector Healthcare
- Industry Drug Manufacturers - General
- Investment Style Large Blend
- Day Range 94.76 – 95.70
- Year Range 76.45 – 105.18
- Market Cap 119.1425 Bil
- Volume / Avg 1.2 Mil / 1.7 Mil
- Price / Sales 2.59
- Price / Book 1.59
- Forward Div Yield 3.73%
- Trailing Div Yield 3.07%
Morningstar‘s Stock Analysis SAN
Valuation
Currency in —
Is it the right time to buy or sell?
Is it the right time to buy or sell?
1-Star Price
INVESTOR
5-Star Price
INVESTOR
Economic Moat
INVESTOR
Capital Allocation
INVESTOR
Sanofi's Strong Position in Immunology and Rare Diseases Helps Support Steady Long-Term Growth
Unlock Our Full Analysis With Morningstar Investor
Company Profile SAN
Business Description
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 15% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Related Articles SAN
Morningstar analysts hand-select direct competitors or comparable companies to provide context on the strength and durability of SAN’s competitive advantage.
Sanofi SA
XPAR: SAN
| Merck & Co Inc
XNYS: MRK
| Pfizer Inc
XNYS: PFE
| Novartis AG Registered Shares
XSWX: NOVN
| |
Price
| 95.40 | 110.71 | 38.97 | 90.17 |
Currency
| EUR | USD | USD | CHF |
Change
| −$0.04 (0.04%) | +$0.39 (0.35%) | −$0.12 (0.31%) | −$0.20 (0.22%) |
Market Cap
| 119.14 Bil | 280.92 Bil | 220.00 Bil | 189.09 Bil |
Industry
| Drug Manufacturers - General | Drug Manufacturers - General | Drug Manufacturers - General | Drug Manufacturers - General |
Sector
|
Healthcare
|
Healthcare
|
Healthcare
|
Healthcare
|
* Trading data in this section is delayed by at least 15 minutes.
FAQs for Sanofi SA Stock
Yes. SAN has a forward dividend yield of 3.73%.
See
SAN’s full dividends and stock split history
on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks,
to compare the relationship between a stock’s price and how it rewards stockholders through dividends.
The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.
Learn more about dividend yield.
SAN’s market cap is 119.14 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares.
It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the
largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.
Learn more about market capitalization.
SAN’s stock style is Large Core.
Style is an investment factor that has a meaningful impact on investment risk and returns.
Style is calculated by combining value and growth scores, which are first individually calculated.
High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.
Learn more about style.
SAN’s price/sales is 2.60.
Price/sales represents the amount an investor is willing to pay for a dollar generated from
a particular company’s sales or revenues.
SAN’s price/forward earnings is 14.35.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates.
The lower the Forward P/E, the cheaper the stock.
SAN’s price/book is 1.72.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets,
based on historical, rather than current, valuations. Historical valuations generally do not reflect
a company’s current market value. Value investors frequently look for companies that have low price/book ratios.
See SAN’s valuation ratios compared to the Market Index.
SAN’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.
Compare SAN’s historical performance against its industry peers and the overall market.